Clinical Trials Browser

Phase 1 × OTHER × Non-squamous Non-small-cell Lung Cancer × Clear all

NCT04012619 2023-08-03

Anlotinib Hydrochloride Combined With AP in Stage IIIB/IIIC/IV Non-squamous Non-small-cell Lung Cancer

Phase 1 Completed

8 enrolled 9 charts

Non-squamous Non-small-cell Lung Cancer